JP2023524445A5 - - Google Patents

Info

Publication number
JP2023524445A5
JP2023524445A5 JP2022565804A JP2022565804A JP2023524445A5 JP 2023524445 A5 JP2023524445 A5 JP 2023524445A5 JP 2022565804 A JP2022565804 A JP 2022565804A JP 2022565804 A JP2022565804 A JP 2022565804A JP 2023524445 A5 JP2023524445 A5 JP 2023524445A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
acid sequence
sequence shown
formulation according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022565804A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023524445A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/029545 external-priority patent/WO2021222347A1/en
Publication of JP2023524445A publication Critical patent/JP2023524445A/ja
Publication of JP2023524445A5 publication Critical patent/JP2023524445A5/ja
Pending legal-status Critical Current

Links

JP2022565804A 2020-04-29 2021-04-28 医薬製剤 Pending JP2023524445A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063017061P 2020-04-29 2020-04-29
US63/017,061 2020-04-29
PCT/US2021/029545 WO2021222347A1 (en) 2020-04-29 2021-04-28 Pharmaceutical formulation

Publications (2)

Publication Number Publication Date
JP2023524445A JP2023524445A (ja) 2023-06-12
JP2023524445A5 true JP2023524445A5 (enExample) 2024-03-28

Family

ID=76099008

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022565804A Pending JP2023524445A (ja) 2020-04-29 2021-04-28 医薬製剤

Country Status (9)

Country Link
US (1) US20230167176A1 (enExample)
EP (1) EP4142789A1 (enExample)
JP (1) JP2023524445A (enExample)
KR (1) KR20230004798A (enExample)
CN (1) CN115461080A (enExample)
AU (1) AU2021265108A1 (enExample)
CA (1) CA3173934A1 (enExample)
IL (1) IL297081A (enExample)
WO (1) WO2021222347A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202415407A (zh) * 2022-06-30 2024-04-16 中國大陸商蘇州創勝醫藥集團有限公司 穩定之包含抗cldn18.2抗體的藥物製劑

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4475196A (en) 1981-03-06 1984-10-02 Zor Clair G Instrument for locating faults in aircraft passenger reading light and attendant call control system
US4447233A (en) 1981-04-10 1984-05-08 Parker-Hannifin Corporation Medication infusion pump
US4439196A (en) 1982-03-18 1984-03-27 Merck & Co., Inc. Osmotic drug delivery system
US4447224A (en) 1982-09-20 1984-05-08 Infusaid Corporation Variable flow implantable infusion apparatus
US4487603A (en) 1982-11-26 1984-12-11 Cordis Corporation Implantable microinfusion pump system
US4486194A (en) 1983-06-08 1984-12-04 James Ferrara Therapeutic device for administering medicaments through the skin
US4596556A (en) 1985-03-25 1986-06-24 Bioject, Inc. Hypodermic injection apparatus
US4751180A (en) 1985-03-28 1988-06-14 Chiron Corporation Expression using fused genes providing for protein product
US4935233A (en) 1985-12-02 1990-06-19 G. D. Searle And Company Covalently linked polypeptide cell modulators
ATE243754T1 (de) 1987-05-21 2003-07-15 Micromet Ag Multifunktionelle proteine mit vorbestimmter zielsetzung
US4790824A (en) 1987-06-19 1988-12-13 Bioject, Inc. Non-invasive hypodermic injection device
US4941880A (en) 1987-06-19 1990-07-17 Bioject, Inc. Pre-filled ampule and non-invasive hypodermic injection device assembly
US5312335A (en) 1989-11-09 1994-05-17 Bioject Inc. Needleless hypodermic injection device
US5064413A (en) 1989-11-09 1991-11-12 Bioject, Inc. Needleless hypodermic injection device
US5383851A (en) 1992-07-24 1995-01-24 Bioject Inc. Needleless hypodermic injection device
CA2409991A1 (en) 2000-05-24 2001-11-29 Imclone Systems Incorporated Bispecific immunoglobulin-like antigen binding proteins and method of production
EP1786918A4 (en) 2004-07-17 2009-02-11 Imclone Systems Inc NEW BISPECIFIC ANTIBODY TETRAVALENT
KR20100052545A (ko) 2007-08-28 2010-05-19 바이오겐 아이덱 엠에이 인코포레이티드 Ｉｇｆ―１ｒ의 다중 에피토프에 결합하는 조성물
TW202037609A (zh) * 2012-11-01 2020-10-16 美商艾伯維有限公司 抗-vegf/dll4雙重可變區域免疫球蛋白及其用途
CN109803640B (zh) * 2016-08-10 2022-01-04 赛特瑞恩股份有限公司 稳定的液体抗流感病毒抗体医药调配物
SMT202500367T1 (it) * 2017-02-02 2025-11-10 Amgen Res Munich Gmbh Composizione farmaceutica a basso ph comprendente costrutti di anticorpo che reclutano le cellule t
UY37726A (es) 2017-05-05 2018-11-30 Amgen Inc Composición farmacéutica que comprende constructos de anticuerpos biespecíficos para almacenamiento y administración mejorados
WO2019020745A1 (en) * 2017-07-28 2019-01-31 F. Hoffmann-La Roche Ag Bispecific antibody formulation

Similar Documents

Publication Publication Date Title
JP7446356B2 (ja) 抗ｒｓｖモノクローナル抗体製剤
JP7057360B2 (ja) 抗－ｃｄ３抗体製剤
US8815236B2 (en) Method for treating multiple sclerosis and crohn's disease
US5932223A (en) Rotavirus vaccine formulations
US20190071496A1 (en) Pharmaceutical formulations of tnf-alpha antibodies
US6616931B1 (en) Rotavirus vaccine formulations
EP2892504B1 (fr) Solution aqueuse de protéine à concentration élevée de viscosité réduite
US6403098B1 (en) Rotavirus vaccine formulations
KR20090021298A (ko) 항-ｅｇｆｒ 항체의 동결건조 제제
AU739916B2 (en) Rotavirus vaccine formulations
WO2023280152A1 (en) Combination therapy for treatment of liver diseases
JP2022513684A5 (enExample)
JP2023538669A5 (enExample)
JP2024540395A5 (enExample)
JP2023524445A5 (enExample)
US20260069688A1 (en) Stable antibody composition
JP7085482B2 (ja) スタフィロコッカス感染症のための凍結乾燥製剤を製造する方法
JP2023524444A5 (enExample)
US20220257702A1 (en) Stable albuvirtide compositions
KR20230167968A (ko) 점도 감소 부형제 조성물 및 이를 포함하는 저점도 고농축 단백질 제형
JP7630625B2 (ja) 改善された凍結乾燥製剤
JP2023501155A5 (enExample)
AU2012201490B2 (en) Method of drug delivery for bone anabolic protein
CN120420429A (zh) 酪氨酸激酶抑制剂在制备治疗肿瘤药物中的用途
HK40093820A (zh) 抗rsv单克隆抗体配制品